Literature DB >> 20559773

The paradoxical role of inflammation in cardiac repair and regeneration.

Bingbing Jiang1, Ronglih Liao.   

Abstract

Inflammation has emerged as a critical biological process contributing to nearly all aspects of cardiovascular diseases including heart failure. Heart failure represents the final consequence of a diverse set of initial insults to the myocardium, among which myocardial infarction (MI) is the most common cause. After MI, the lack of perfusion often leads to the death of cardiomyocytes. The necrotic cells trigger a cascade of inflammatory pathways that work to clear the dead cells and matrix debris, as well as to repair and heal damaged tissues. For the heart, an organ with limited regeneration capacity, the consequence of MI (termed post-MI remodeling) comprises a series of structural and functional changes, including scar formation at the infarct zone, reactive hypertrophy of the remaining cardiomyocytes at the noninfarct area, ventricular chamber dilatation, and molecular changes marked by fetal gene up-regulation, all of which have been linked to the activation of the inflammatory pathways. Inadequate or excessive inflammatory response may lead to improper cellular repair, tissue damage, and dysfunction. Herein, we summarize the current understanding of the role of inflammation in cardiac injury and repair and put forth the hypothesis that temporally regulated activation and suppression of inflammation may be critical for achieving effective cardiac repair and regeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559773     DOI: 10.1007/s12265-010-9193-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  97 in total

1.  Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

Authors:  Geoffrey B Johnson; Gregory J Brunn; Yuzo Kodaira; Jeffrey L Platt
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

2.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

3.  Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1.

Authors:  Raksha Jain; Philip W Shaul; Zea Borok; Brigham C Willis
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-22       Impact factor: 6.914

4.  FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.

Authors:  Felix B Engel; Patrick C H Hsieh; Richard T Lee; Mark T Keating
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-10       Impact factor: 11.205

5.  Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis.

Authors:  P E Tummala; X L Chen; C L Sundell; J B Laursen; C P Hammes; R W Alexander; D G Harrison; R M Medford
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

6.  Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.

Authors:  Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Ou-Li Wang; Adam B Stein; Greg Hunt; Jai Varma; Yu-Ting Xuan; Wen-Jian Wu; Wei Tan; Xiaoping Zhu; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

Review 7.  TGF-beta1 and angiotensin networking in cardiac remodeling.

Authors:  Stephan Rosenkranz
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

Review 8.  The role of IL-1 in the pathogenesis of heart disease.

Authors:  Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-05-29       Impact factor: 4.291

9.  IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.

Authors:  Buddhadeb Dawn; Yu-Ting Xuan; Yiru Guo; Arash Rezazadeh; Adam B Stein; Greg Hunt; Wen-Jian Wu; Wei Tan; Roberto Bolli
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

10.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  26 in total

1.  Phenotypic and functional alterations on inflammatory peripheral blood cells after acute myocardial infarction.

Authors:  Tiago Carvalheiro; Isabel Velada; Ana Valado; Fernando Mendes; António Martinho; Natália António; Lino Gonçalves; Luís Providência; Maria Luísa Pais; Artur Paiva
Journal:  J Cardiovasc Transl Res       Date:  2012-04-21       Impact factor: 4.132

2.  Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart.

Authors:  Holger Lörchner; Jochen Pöling; Praveen Gajawada; Yunlong Hou; Viktoria Polyakova; Sawa Kostin; Juan M Adrian-Segarra; Thomas Boettger; Astrid Wietelmann; Henning Warnecke; Manfred Richter; Thomas Kubin; Thomas Braun
Journal:  Nat Med       Date:  2015-03-09       Impact factor: 53.440

3.  Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function.

Authors:  Insa M Schmidt; Isaac E Hall; Sujata Kale; Sik Lee; Chuan-Hua He; Yashang Lee; Geoffrey L Chupp; Gilbert W Moeckel; Chun Geun Lee; Jack A Elias; Chirag R Parikh; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 10.121

Review 4.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 5.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

6.  MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.

Authors:  R Dale Brown; S Kelly Ambler; Min Li; Timothy M Sullivan; Lauren N Henry; Joseph T Crossno; Carlin S Long; Timothy P Garrington; Kurt R Stenmark
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-02       Impact factor: 4.733

7.  Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system.

Authors:  Vijayalakshmi Sridharan; Preeti Tripathi; Sunil K Sharma; Eduardo G Moros; Peter M Corry; Benjamin J Lieblong; Elena Kaschina; Thomas Unger; Christa Thöne-Reineke; Martin Hauer-Jensen; Marjan Boerma
Journal:  Cancer Res       Date:  2012-08-03       Impact factor: 12.701

Review 8.  Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.

Authors:  Erik Tandberg Askevold; Lars Gullestad; Christen P Dahl; Arne Yndestad; Thor Ueland; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2014-06

9.  JNK2 promotes endothelial cell alignment under flow.

Authors:  Cornelia Hahn; Chong Wang; A Wayne Orr; Brian G Coon; Martin Alexander Schwartz
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

Review 10.  Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?

Authors:  Satenik H Adamyan; Knarik R Harutyunyan; Hermine T Abrahamyan; Drastamat N Khudaverdyan; Souren Mkrtchian; Anna S Ter-Markosyan
Journal:  J Investig Med       Date:  2021-05-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.